Evidence map›Paper›PMID 34109489›Full record

ArticleEuropean radiology2022

Machine learning based on the multimodal connectome can predict the preclinical stage of Alzheimer's disease: a preliminary study.

Haifeng Chen, Weikai Li, Xiaoning Sheng, Qing Ye, Hui Zhao, Yun Xu, Feng Bai, Alzheimer’s Disease Neuroimaging Initiative

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haifeng Chen *Department of Neurology, Affiliated Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.
Weikai Li *College of Computer Science and Technology, Nanjing University of Aeronautics and Astronautics, Nanjing, China.
Xiaoning ShengDepartment of Neurology, Affiliated Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.
Qing YeDepartment of Neurology, Affiliated Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.
Hui ZhaoDepartment of Neurology, Affiliated Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.
Yun XuDepartment of Neurology, Affiliated Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.
Feng BaiDepartment of Neurology, Affiliated Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China. baifeng@njglyy.com.
Alzheimer’s Disease Neuroimaging Initiative

Funding

Jiangsu Province Key Medical Discipline ZDXKA2016020Jiangsu Provincial Key Medical Talents ZDRCA2016085Key Research and Development Program of Jiangsu Province of China BE2016610National Natural Science Foundation of China 81671665National Natural Science Foundation of China 81822013the National Key Research and Development Program of China 2016YFC1300500-504
6 · The paper itself

Abstract

objectivesSubjective cognitive decline (SCD) may be a preclinical stage of Alzheimer's disease (AD). Neuroimaging studies suggest that abnormal brain connectivity plays an important role in the pathophysiology of SCD. However, most previous studies focused on single modalities only. Multimodal combinations can more effectively utilize various information and little is known about their diagnostic value in SCD.

methodsOne hundred ten SCD individuals and well-matched healthy controls (HCs) were recruited in this study (the primary sample: 35 SCD and 36 HC; the validation sample: 21 SCD and 18 HC). Multimodal imaging data were used to construct functional, anatomical, and morphological networks, respectively. These networks were used in combination with a multiple kernel learning-support vector machine to predict SCD individuals. We validated our model on another independent sample. Multiple linear regression (MLR) analyses were conducted to investigate the relationships among network metrics, cognition, and pathological biomarkers.

resultsWe found that the characteristics identified from the multimodal network were primarily located in the default mode network (DMN) and salience network (SN), achieving an accuracy of 88.73% (an accuracy of 79.49% for an independent sample) based on the integration of the three modalities. MLR analyses showed that increased AV45 SUVRs were significantly associated with impaired memory function, the enhanced functional connectivity, and the decreased morphological connectivity.

conclusionThis study suggests that abnormal multimodal connections within DMN and SN can be used as effective biomarkers to identify SCD and provide insight into understanding the pathophysiological mechanisms underlying SCD. KEY POINTS: • Multimodal brain networks improve the detection accuracy of SCD. • Abnormal connections within DMN and SN can be used as effective biomarkers for the identification of SCD.

Indexed as

Alzheimer DiseaseConnectomeBrainHumansMachine LearningMagnetic Resonance ImagingNeuroimagingCognitive declineDefault mode networkLinear modelsMachine learningMultimodal imaging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.